13 July 2023
Assura plc
Exercise of Nil Cost Options under PSP
Assura plc ("Assura"), the leading primary care property investor and developer announces that on 12 July 2023, the PDMRs listed below exercised their 2020 PSP awards.
The table below shows the number of shares vesting, the number of shares sold to satisfy income tax and national insurance liabilities, the number of shares sold for the benefit of the Assura Community Fund and the number of shares received following the sales.
|
Number of Shares awarded |
Number of shares sold to satisfy income tax and national insurance liabilities |
Additional shares sold on behalf of the Assura Community Fund |
Additional shares sold |
Number of shares after shares sold
|
Jonathan Murphy |
183,890 |
(86,428) |
(18,389) |
- |
79,073 |
Jayne Cottam |
103,351 |
(48,575) |
- |
- |
54,776 |
The Remuneration Committee of Assura had agreed that sufficient shares may be sold by each PDMR to cover the arising income tax and national insurance liabilities and that Mr Murphy could sell 18,389 shares to make a contribution to the Assura Community Fund. The relevant market price for taxation purposes is £0.4601 per share.
As a result of the above, the PDMR's shareholding and those of their connected persons is as follows:
|
Shareholding on 11 July 2023 |
Shareholding post exercise |
Jonathan Murphy |
2,860,873 |
2,939,946 |
Jayne Cottam |
647,606 |
702,382 |
Following the allotment, Mr Murphy transferred 79,073 shares to his wife. The total beneficial holding remains the same.
The Notification of Dealing Form for the PDMRs can be found below.
This notification is made in accordance with the Market Abuse Regulation.
Notification of dealing form
1 |
Details of the person discharging managerial responsibilities/person closely associated
|
|||||||
a) |
Name
|
Jonathan Murphy |
||||||
2 |
Reason for the notification
|
|||||||
a) |
Position/status
|
CEO |
||||||
b) |
Initial notification/ Amendment
|
Initial notification |
||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||||
a) |
Name
|
Assura plc |
||||||
b) |
LEI
|
21380026T19N2Y52XF72 |
||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 10 pence each
GB00BVGBWW93 |
||||||
b) |
Nature of the transaction
|
Vesting of share awards under PSP
|
||||||
c) |
Price(s) and volume(s)
|
|
||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
N/A |
||||||
e) |
Date of the transaction
|
12 July 2023 |
||||||
f) |
Place of the transaction
|
XLON |
||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 10 pence each
GB00BVGBWW93 |
||||||
b) |
Nature of the transaction
|
Sale of shares to satisfy tax and national insurance liabilities and to make a contribution to the Assura Community Fund.
|
||||||
c) |
Price(s) and volume(s)
|
|
||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
|
||||||
e) |
Date of the transaction
|
12 July 2023 |
||||||
f) |
Place of the transaction
|
XLON |
||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 10 pence each
GB00BVGBWW93 |
||||||
b) |
Nature of the transaction
|
Transfer shares to Mr Murphy's wife.
|
||||||
c) |
Price(s) and volume(s)
|
|
||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
|
||||||
e) |
Date of the transaction
|
12 July 2023 |
||||||
f) |
Place of the transaction
|
XLON |
1 |
Details of the person discharging managerial responsibilities/person closely associated
|
|||||||
a) |
Name
|
Jayne Cottam |
||||||
2 |
Reason for the notification
|
|||||||
a) |
Position/status
|
CFO |
||||||
b) |
Initial notification/ Amendment
|
Initial notification |
||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||||
a) |
Name
|
Assura plc |
||||||
b) |
LEI
|
21380026T19N2Y52XF72 |
||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 10 pence each
GB00BVGBWW93 |
||||||
b) |
Nature of the transaction
|
Vesting of share awards under PSP
|
||||||
c) |
Price(s) and volume(s)
|
|
||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
N/A |
||||||
e) |
Date of the transaction
|
12 July 2023 |
||||||
f) |
Place of the transaction
|
XLON |
||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 10 pence each
GB00BVGBWW93 |
||||||
b) |
Nature of the transaction
|
Sale of shares to satisfy tax and national insurance liabilities
|
||||||
c) |
Price(s) and volume(s)
|
|
||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
|
||||||
e) |
Date of the transaction
|
12 July 2023 |
||||||
f) |
Place of the transaction
|
XLON |
- ENDS -
For more information, please contact:
Assura plc |
Tel: 0161 515 2043 |
Orla Ball, General Counsel David Purcell, Investor Relations Director
|
Email: Investor@assura.co.uk |
FGS Global Gordon Simpson |
Tel: 0207 251 3801 Email: Assura@fgsglobal.com |
Notes to Editors
Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.
A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2023, Assura's portfolio was valued at £2.7 billion.
At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026.
Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association